Sale of BASF's pharmaceutical business to Abbott completed
05-Mar-2001
Eggert Voscherau, a member of BASF's Board of Executive Directors, said: "The timing of the transaction has been ideal for all parties. The excellent cooperation with Abbott is a sign off how well BASF Pharma fits into its new business setting."
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.